» Articles » PMID: 30949305

Fast Methods for Prediction of Aldehyde Oxidase-Mediated Site-of-Metabolism

Overview
Specialty Biotechnology
Date 2019 Apr 6
PMID 30949305
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aldehyde Oxidase (AO) is an enzyme involved in the metabolism of aldehydes and -containing heterocyclic compounds. Many drug compounds contain heterocyclic moieties, and AO metabolism has lead to failure of several late-stage drug candidates. Therefore, it is important to take AO-mediated metabolism into account early in the drug discovery process, and thus, to have fast and reliable models to predict the site of metabolism (SOM). We have collected a dataset of 78 substrates of human AO with a total of 89 SOMs and 347 non-SOMs and determined atomic descriptors for each compound. The descriptors comprise NMR shielding and ESP charges from density functional theory (DFT), NMR chemical shift from ChemBioDraw, and Gasteiger charges from RDKit. Additionally, atomic accessibility was considered using 2D-SASA and relative span descriptors from SMARTCyp. Finally, stability of the product, the metabolite, was determined with DFT and also used as a descriptor. All descriptors have AUC larger than 0.75. In particular, descriptors related to the chemical shielding and chemical shift (AUC = 0.96) and ESP charges (AUC = 0.96) proved to be good descriptors. We recommend two simple methods to identify the SOM for a given molecule: 1) use ChemBioDraw to calculate the chemical shift or 2) calculate ESP charges or chemical shift using DFT. The first approach is fast but somewhat difficult to automate, while the second is more time-consuming, but can easily be automated. The two methods predict correctly 93% and 91%, respectively, of the 89 experimentally observed SOMs.

Citing Articles

Machine Learning in Early Prediction of Metabolism of Drugs.

Lettieri M, Rodda M, Carlucci V Methods Mol Biol. 2024; 2834:275-291.

PMID: 39312170 DOI: 10.1007/978-1-0716-4003-6_13.


Transfer learning enhanced graph neural network for aldehyde oxidase metabolism prediction and its experimental application.

Xiong J, Cui R, Li Z, Zhang W, Zhang R, Fu Z Acta Pharm Sin B. 2024; 14(2):623-634.

PMID: 38322350 PMC: 10840476. DOI: 10.1016/j.apsb.2023.10.008.


In Silico Prediction of Metabolic Reaction Catalyzed by Human Aldehyde Oxidase.

Huang M, Zhu K, Wang Y, Lou C, Sun H, Li W Metabolites. 2023; 13(3).

PMID: 36984889 PMC: 10059660. DOI: 10.3390/metabo13030449.


Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds.

Lazzara P, Moore T RSC Med Chem. 2021; 11(1):18-29.

PMID: 33479602 PMC: 7451012. DOI: 10.1039/c9md00396g.

References
1.
CHRISTENSEN E, Andersen J, Pedersen H, Jensen K, Dalgaard L . Metabolites of [(14)C]-5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3, 6-tetrahydropyridine in mice, rats, dogs, and humans. Drug Metab Dispos. 1999; 27(11):1341-9. View

2.
Torres R, Korzekwa K, McMasters D, Fandozzi C, Jones J . Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase. J Med Chem. 2007; 50(19):4642-7. DOI: 10.1021/jm0703690. View

3.
Shelley J, Cholleti A, Frye L, Greenwood J, Timlin M, Uchimaya M . Epik: a software program for pK( a ) prediction and protonation state generation for drug-like molecules. J Comput Aided Mol Des. 2007; 21(12):681-91. DOI: 10.1007/s10822-007-9133-z. View

4.
Alfaro J, Jones J . Studies on the mechanism of aldehyde oxidase and xanthine oxidase. J Org Chem. 2008; 73(23):9469-72. PMC: 2765548. DOI: 10.1021/jo801053u. View

5.
Zhang X, Liu H, Weller P, Zheng M, Tao W, Wang J . In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor. Pharmacogenomics J. 2010; 11(1):15-24. DOI: 10.1038/tpj.2010.8. View